Keywords: ترومبوسیتوپنی ایمنی; Innate lymphoid cells; Immune thrombocytopenia; Spleen;
مقالات ISI ترومبوسیتوپنی ایمنی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ترومبوسیتوپنی ایمنی; Immune thrombocytopenia; Paediatric; Childhood; Thrombopoietin analogues; Trombocitopenia inmune; PediatrÃa; Infancia; Análogos de la trombopoyetina;
Keywords: ترومبوسیتوپنی ایمنی; Trombocitopenia inmune; PediatrÃa; Infancia; Análogos de la trombopoyetina; Immune thrombocytopenia; Paediatric; Childhood; Thrombopoietin analogues;
Keywords: ترومبوسیتوپنی ایمنی; Hashimoto thyroiditis; Immune thrombocytopenia; Primary biliary cirrhosis;
Keywords: ترومبوسیتوپنی ایمنی; AIHA; autoimmune hemolytic anemia; B2M; β2-microglobulin; BR; bendamustine and rituximab; BTK; Bruton tyrosine kinase; CLL; chronic lymphocytic leukemia; CR; complete remission; FCR; fludarabine; cyclophosphamide; and rituximab; FISH; fluorescence in sit
Keywords: ترومبوسیتوپنی ایمنی; immune thrombocytopenia; ITP; autoimmune hemolytic anemia; AIHA; pediatric;
Keywords: ترومبوسیتوپنی ایمنی; CTLs; CD8+ T lymphocytes; ELISA; enzyme-linked immunosorbent assay; ITP; immune thrombocytopenia; IBD; inflammatory bowel disease; OA; osteoarthritis; PGRN; progranulin; rPGRN; recombinant progranulin; RA; rheumatoid arthritis; SLE; systemic lupus erythem
Keywords: ترومبوسیتوپنی ایمنی; Chinese; Immune thrombocytopenia; IGF-1; IGF-1R rs 2229765; Polymorphism;
Keywords: ترومبوسیتوپنی ایمنی; Immune thrombocytopenia; Platelets; BeadCheap technology; Genotyping; HPA;
Keywords: ترومبوسیتوپنی ایمنی; Evans' syndrome; Autoimmune hemolytic anemia; Immune thrombocytopenia; Bicytopenia; SÃndrome de Evans; Anemia hemolÃtica autoinmune; Trombocitopenia inmune; Bicitopenia;
Keywords: ترومبوسیتوپنی ایمنی; Immune thrombocytopenia; Population-based study; Incidence; Treatment;
Keywords: ترومبوسیتوپنی ایمنی; bleeding events; cost analysis; hemorrhage; immune thrombocytopenia;
Keywords: ترومبوسیتوپنی ایمنی; Accessory spleen; Splenculi; Meta-analysis; Idiopathic thrombocytopenic purpura; Immune thrombocytopenia;
Keywords: ترومبوسیتوپنی ایمنی; Immune thrombocytopenia; Idiopathic thrombocytopenic purpura; Splenectomy; Thrombopoietin mimetics; Anti-D immunoglobulin;
Keywords: ترومبوسیتوپنی ایمنی; Immune thrombocytopenia; Autoimmune hemolytic anemia; Thrombotic thrombocytopenic purpura; Splenectomy; Second-line treatment;
Keywords: ترومبوسیتوپنی ایمنی; Autoimmune disease; Immune thrombocytopenia; Medications; Infection;
Keywords: ترومبوسیتوپنی ایمنی; Nivolumab; Non-small-cell-lung cancer; Programmed death 1; Immune thrombocytopenia; Immune-related adverse events;
Keywords: ترومبوسیتوپنی ایمنی; Antiphospholipid syndrome; Catastrophic antiphospholipid syndrome; Romiplostim; Immune thrombocytopenia;
Keywords: ترومبوسیتوپنی ایمنی; Immune thrombocytopenia; Dapsone; Danazol; Hydroxychloroquine; Vinca-alkaloids;
Keywords: ترومبوسیتوپنی ایمنی; Chronic lymphocytic leukemia; Autoimmune cytopenias; Autoimmune hemolytic anemia; Immune thrombocytopenia;
Keywords: ترومبوسیتوپنی ایمنی; Thrombocytopenia; Immune thrombocytopenia; Heparin-induced thrombocytopenia; Thrombotic thrombocytopenia purpura; Atypical hemolytic uremic syndrome;
Keywords: ترومبوسیتوپنی ایمنی; Immune thrombocytopenia; Splenectomy; Rituximab; Thrombopoietin receptor agonist; Pharmacoepidemiology
Keywords: ترومبوسیتوپنی ایمنی; Immune thrombocytopenia; Autoimmune hemolytic anemia; Thrombotic thrombocytopenia purpura; Autoimmune neutropenia; Pregnancy
Keywords: ترومبوسیتوپنی ایمنی; Chinese; eltrombopag; immune thrombocytopenia; platelet count; population pharmacokinetics/pharmacodynamics;
Keywords: ترومبوسیتوپنی ایمنی; ACIP; Advisory Committee on Immunization Practices; ADEM; acute disseminated encephalomyelitis; AE; adverse events; AIDP; acute inflammatory demyelinating polyradiculoneuropathy; AMAN; acute motor axonal neuropathy; AMSAN; acute motor and sensory neuropat
Keywords: ترومبوسیتوپنی ایمنی; AIHA; autoimmune hemolytic anemia; ASH; American Society of Hematology; CLL; chronic lymphocytic leukemia; CMV; cytomegalovirus; CVID; common variable immunodeficiency; GPRD; General Practice Research Database; DIC; disseminated intravascular coagulation;
Keywords: ترومبوسیتوپنی ایمنی; CHOC; Children's Hospital of Orange County; ITP; Immune thrombocytopenia; IV; Intravenous; IVIG; Intravenous immunoglobulin; MF; Myelofibrosis; TPO; Thrombopoietin; WCMC; Weill Cornell Medical Center;
Keywords: ترومبوسیتوپنی ایمنی; Immune thrombocytopenia; Pyrazole derivatives; Phagocytosis inhibitors; Structure-activity relationship;
Keywords: ترومبوسیتوپنی ایمنی; Immune thrombocytopenia; Phagocytosis; IVIG; Small molecule inhibitors; Macrophages;
Keywords: ترومبوسیتوپنی ایمنی; ITP; Immune thrombocytopenia; IGIV; immunoglobulin intravenous;
Keywords: ترومبوسیتوپنی ایمنی; Immune thrombocytopenia; Immune dysregulation; Thrombopoietin
Keywords: ترومبوسیتوپنی ایمنی; Autoantibody; Immune thrombocytopenia; Intravenous immunoglobulin; Regulatory T cells; Thrombopoietin
Keywords: ترومبوسیتوپنی ایمنی; Immune thrombocytopenia; Rituximab; Eltrombopag; Romiplostim; Splenectomy; Thrombosis
Increased ADAM10 expression in patients with immune thrombocytopenia
Keywords: ترومبوسیتوپنی ایمنی; Immune thrombocytopenia; ADAM10; TIMP3; FasL; LAG-3;
Anti-c-Mpl antibodies in immune thrombocytopenia suppress thrombopoiesis and decrease response to rhTPO
Keywords: ترومبوسیتوپنی ایمنی; (anti-c-Mpl) antibodies; anti-TPO receptor; anti-c-Mpl+; anti-c-Mpl-antibody-positive; anti-c-Mplâ; anti-c-Mpl-antibody-negative; ITP; immune thrombocytopenia; IVIG; intravenous immunoglobulin; TPO; thrombopoietin; TPO-RAs; TPO receptor agonists; rhTPO;
Essential thrombocytemia following immune thrombocytopenia with JAK2V617F mutation
Keywords: ترومبوسیتوپنی ایمنی; Essential thrombocytemia; Immune thrombocytopenia; JAK2V617F mutation;
Fine tuning subsets of CD4+ T cells by low-dosage of IL-2 and a new therapeutic strategy for autoimmune diseases
Keywords: ترومبوسیتوپنی ایمنی; aa; Amino acids; A region; Acidic region of IL-2Rβ; AKT; Protein kinase B; AA; Alopecia Areata; CTLA-4; Cytotoxic T lymphocyte antigen-4; cDNA; Complementary DNA; Foxp3; Forkhead box P3; GVHD; Chronic graft-versus-host disease; HCV; Hepatitis C virus; hd
Abnormal differentiation of B cells and megakaryocytes in patients with Roifman syndrome
Keywords: ترومبوسیتوپنی ایمنی; B cells; platelets; RNA processing; Roifman syndrome; APRIL; A proliferation-inducing ligand; BAFF; B-cell activating factor; BAFF-R; B-cell activating factor receptor; BCR; B-cell receptor; BeviMed; Bayesian Evaluation of Variant Involvement in Mendelian
Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations
Keywords: ترومبوسیتوپنی ایمنی; Autoimmune cytopenias; Immune checkpoint deficiencies; Extensive genetic screening; LRBA and CTLA-4 deficiencies; ES; Evans syndrome; AIHA; Autoimmune hemolytic anemia; ITP; Immune thrombocytopenia; ALPS; Autoimmune lymphoproliferative syndrome; CTLA-4; C
MYH9: Structure, functions and role of non-muscle myosin IIA in human disease
Keywords: ترومبوسیتوپنی ایمنی; NM IIA; non-muscle myosin IIA; NMHC IIA; non-muscle myosin heavy chain IIA; NM IIB; non-muscle myosin IIB; NMHC IIB; non-muscle myosin heavy chain IIB; NM IIC; non-muscle myosin IIC; NMHC IIC; non-muscle myosin heavy chain IIC; NM II; non-muscle myosin II
Mise au pointÃpidémiologie et pharmacoépidémiologie du purpura thrombopénique immunologiqueEpidemiology and pharmacoepidemiology of immune thrombocytopenia
Keywords: ترومبوسیتوپنی ایمنی; Thrombopénie immunologique; Ãpidémiologie; Pharmacoépidémiologie; Immune thrombocytopenia; Epidemiology; Pharmacoepidemiology;
SÃndrome de Evans en lactantes
Keywords: ترومبوسیتوپنی ایمنی; SÃndrome de Evans; Anemia hemolÃtica autoinmune; Trombocitopenia inmune; Bicitopenia; Evans syndrome; Autoimmune hemolytic anemia; Immune thrombocytopenia; Bicytopenia;
B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopenia
Keywords: ترومبوسیتوپنی ایمنی; Immune thrombocytopenia; T follicular helper cells; Rituximab; ADCC; antibody-dependent cell-mediated cytotoxicity; AID; autoimmune diseases; FC; fold change; GC; germinal center; ITP; immune thrombocytopenia; PBMC; peripheral blood mononuclear cells; PBL
Article originalThromboses sous agonistes du récepteur de la thrombopoïétine au cours du purpura thrombopénique immunologique. Ãtude rétrospective multicentrique en FranceThrombosis during thrombopoietin receptor agonist treatment for immune thrombo
Keywords: ترومبوسیتوپنی ایمنی; Thrombopénie immunologique; Thromboses; Agoniste du récepteur de la thrombopoïétine; Romiplostim; Eltrombopag; Immune thrombocytopenia; Thrombosis; Thrombopoietin receptor agonist; Romiplostim; Eltrombopag;
Original ResearchPrevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis
Keywords: ترومبوسیتوپنی ایمنی; Immunotherapy; Connective tissue diseases; Rheumatic diseases; Immune thrombocytopenia;
Place de la transfusion plaquettaire dans les thrombopénies immunes néonatales
Keywords: ترومبوسیتوپنی ایمنی; Transfusion plaquettaire; Thrombopénies immunes; Allo-immunisation plaquettaire; Thrombopénies néonatales; Grossesse; Auto-immunité; Platelet transfusion; Immune thrombocytopenia; Platelet allo-immunisation; Neonatal thrombocytopenia; Pregnancy; Auto-
Increased RUNX1 expression in patients with immune thrombocytopenia
Keywords: ترومبوسیتوپنی ایمنی; Immune thrombocytopenia; Runt-related transcription factor 1; Retinoic acid receptor-related orphan receptor-γt; IL-17;
Targeting autophagy as a potential therapeutic approach for immune thrombocytopenia therapy
Keywords: ترومبوسیتوپنی ایمنی; Autophagy; Immune responses; Autoimmunity; Immune thrombocytopenia;
Platelet proteomics in diagnostic differentiation of primary immune thrombocytopenia using SELDI-TOF-MS
Keywords: ترومبوسیتوپنی ایمنی; Immune thrombocytopenia; SELDI-TOF-MS; Platelet; Proteomics; Artificial neural network;
Differences in microbial metabolites in urine headspace of subjects with Immune Thrombocytopenia (ITP) detected by volatile organic compound (VOC) analysis and metabolomics
Keywords: ترومبوسیتوپنی ایمنی; Immune Thrombocytopenia; ITP; Metabolomics; Volatile organic compounds; VOCs; Selective ion flow tube mass spectrometry (SIFT-MS)